BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16854315)

  • 1. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
    Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
    Pang JZ; Qin LX; Wang QQ; Ren N; Sun BS; Lin GL; Ye QH; Liu YK; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):906-9. PubMed ID: 18171524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between microsatellite alterations on chromosome 8 and clinicopathological characteristics in hepatocellular carcinoma].
    Zhang SH; Cong WM; Xian ZH; Wu MC
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):429-32. PubMed ID: 15498212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of micro satellite alterations on chromosome 4 in hepatocellular carcinoma].
    Zhang SH; Cong WM; Xian ZH; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):223-6. PubMed ID: 15099473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
    Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
    Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
    Schwarzenbach H; Müller V; Stahmann N; Pantel K
    Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
    Li X; Ding M; Lai B
    Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
    Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
    Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
    Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
    Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
    Li S; Wang H; Zhang C
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
    Zhang H; Li Z; Chen M; Zhang G; Xu K
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.
    Goessl C; Heicappell R; Münker R; Anker P; Stroun M; Krause H; Müller M; Miller K
    Cancer Res; 1998 Oct; 58(20):4728-32. PubMed ID: 9788629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
    Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite alterations in serum DNA of patients with colorectal cancer.
    Kölble K; Ullrich OM; Pidde H; Barthel B; Diermann J; Rudolph B; Dietel M; Schlag PM; Scherneck S
    Lab Invest; 1999 Sep; 79(9):1145-50. PubMed ID: 10496533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error.
    Kawai H; Suda T; Aoyagi Y; Isokawa O; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Tsukada K; Mori S; Shimizu T; Suzuki Y; Abe Y; Takahashi T; Nomoto M; Asakura H
    Hepatology; 2000 Jun; 31(6):1246-50. PubMed ID: 10827149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
    Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
    Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
    Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
    BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The microsatellite instability and loss of heterozygosity in chromosome translocation breakpoint in leukemia].
    Fu Y; Zhu P; Wang W; Liu Y; Xue H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):271-3. PubMed ID: 9758870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.